Paul Guyre PhD

Dr. Paul M. Guyre is VP for Research and Discovery and is currently the Principal Investigator for R&D programs to develop antibacterial, antiviral and immune-enhancing small molecules and antibodies. He is also an Active Emeritus Professor of Microbiology and Immunology at the Geisel School of Medicine at Dartmouth. Prior to Celdara, Paul was co-founder of Medarex, the company that produced many FDA-approved antibodies including the cancer checkpoint antibodies ipilimumab and nivolumab. Paul received his BA in Biology from Montclair State College and his MS and PhD degrees in Microbiology at the University of New Hampshire.